‘Doxorubicin and MBO-asGCS Oligonucleotide Loaded Lipid Nanoparticles Overcome Multidrug Resistance in Adriamycin Resistant Ovarian Cancer Cells (NCI/ADR-RES)

類似資料

• Mixed Backbone Antisense Glucosylceramide Synthase Oligonucleotide (MBO-asGCS) loaded Solid Lipid Nanoparticles: In Vitro Characterization and Reversal of Multidrug Resistance in NCI/ADR-RES Cells
  著者:: Siddiqui, Akhtar, 等
  出版事項: (2010)
• In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells
  著者:: Morsy, Mohamed A., 等
  出版事項: (2020)
• Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance
  著者:: Vert, Anna, 等
  出版事項: (2018)
• Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
  著者:: Sun, Wenxia, 等
  出版事項: (2013)
• Synthesis, Tubulin Assembly, and Antiproliferative Activity Against MCF7 and NCI/ADR-RES Cancer Cells of 10-O-Acetyl-5′-hydroxybutitaxel
  著者:: Ge, Haibo, 等
  出版事項: (2008)